A major advance in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in many forms of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research